Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: A double-blind, multicentre study

International Clinical Psychopharmacology

Volumn 11, Issue 3, 1996, Pages 157-164

  Haffmans, P M J ^a   Timmerman, L ^b,d   Hoogduin, C A L ^c   Van Laarhoven, J H M ^d   Van Gool, A R ^d   Coppens, J M G ^d   Winter, R ^d   Schmidt, R ^d   Dijkstra, H N ^d   Querido, A L ^d   Offermans, J M J F ^d   Droogleever Fortuyn, H A ^d   Fiolet, J ^d   Ligtenberg, H H ^d   Venema, H C P ^d   Zwartjes, G C ^d   Van Langevelde, A M ^d   Batelaan, B ^d   Notten, P ^d   Boom, A J ^d   Dekker, D ^d   Eland, W ^d   Meijer, P ^d   Van Beuzekom, C ^d   Dries, P ^d   Kabela, M ^d   Noordanus, W J ^d   more..

^a Psychiatric Centre Bloemendaal   (Netherlands)

^b Delta Psychiatrisch Ziekenhuis   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d NONE

Author keywords

Citalopram; Depression; Fluvoxamine; Gastrointestinal side effects

Indexed keywords

CITALOPRAM; FLUVOXAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTPATIENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 10244254025     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199609000-00002     Document Type: Article

References (33)

1. Asberg M, Eriksson B, Mårtensson B, Träskman-Bendz L and Wagner A (1986) Therapeutic effects of serotonin uptake inhibitors in depression. Journal of Clinical Psychiatry, 47 (Suppl 4), 23-35.
2. Bateman DN and Chaplin S (1988) Centrally acting drugs. British Medical Journal, 296, 417-419.
3. Bech P and Cialdella P (1992) Citalopram in depression - meta-analysis of intended and unintended effects. International Clinical Psychopharmacology, 6 (Suppl 5), 45-54.
4. Bech P, Kastrup M and Rafaelsen OJ (1989) In: Minicompendium van beoordelingsschalen in de psychiatrie Vertaling, (Eds HAH D'Haenen and WMA Verhoeven), pp. 47-58. VUB Press, Brussels.
5. Benfield P and Ward A (1986) Fluvoxamine; a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs, 32, 481-508.
6. Burrows GD, McIntyre IM, Judd FK and Norman TR (1988) Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness. Journal of Clinical Psychiatry, 49 (Suppl 8), 18-22.
7. Curzon G. Transmitter amines in depression. Psychological Medicine (1982), 12, 465-470.
8. Dencker SJ and Høpfner Petersen HE (1988) Side effect profile of citalopram and reference antidepressant in depression. XXII Nordiske Psykiater Kongres, Reykjavik, 10-13 August 1988.
9. Dijkstra P (1974) De zelfbeoordelingsschaal voor depressie van Zung. In: Stemming en Ontstemming, (Eds HM van Praag and HGM Rooymans), pp. 98-120. De Erven Bohn, Amsterdam.
10. DUAG (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology, 90, 131-138.
11. Gravem A, Amthor KF, Astrup C, Eigen K, Gjessing LR, Gunby B et al. (1987) A doubleblind comparison of citalopram (Lu 10171) and amitriptyline in depressed patients. Acta Psychiatrica Scandinavica, 75, 478-486.
12. Guscott R and Grof P (1991) The clinical meaning of refractory depression: a review for the clinician. American Journal of Psychiatry, 148, 695-704.
13. Guy W (1976) ECDEU Assessment Manual Psychopharmacology US Department of Health, Welfare and Education, Rockville, 217-222.
14. Hamilton M (1967) Development of a rating scale for primary depressive illness. British Journal of Sociology and Clinical Psychology, 6, 278-295.
15. Hyttel J (1982) Citalopram pharmacological profile of a specific serotonin (5-HT) uptake inhibitor with antidepressant activity. Progress in Neuro-Psychopharmacology Biology and Psychiatry, 6, 277-295.
16. Hyttel J (1988) Citalopram; the pharmacological characteristics of the most selective inhibitor of serotonin uptake. XXII Nordisk Psykiater Kongres, Reykjavik, 10-13 August 1988.
17. Hyttel J (1993) Comparative pharmacology of selective serotonin re-uptake inhibitors (SSRIs). Nord Journal of Psychiatry, 47 (Suppl 30), 5-12.
18. Hyttel J and Larsen JJ (1985) Serotonin selective antidepressants. Acta Pharmacologica et Toxicologica, 56 (Suppl 1), 146-153.
19. Kamp JS and Haffmans PMJ (1989) UKU bijwerkingenschaal, Internal Report.
20. Kasper S, Fuger J and Möller H-J (1992) Comparative efficacy of antidepressants. Drugs, 43 (Suppl 2), 11-23.
21. Lane R, Baldwin D and Preskorn S (1995) The SSRI's: advantages, disadvantages and differences. Journal of Psychopharmacology, 9, 163-178.
22. Lapin IP and Oxenkrug GF (1969) Intensification of the central serotoninergic processes as possible determinant of the thymoleptic effect. Lancet, 1, 132-136.
23. Leonard BE (1988) Pharmacological effects of serotonin (5-HT) uptake inhibitors. Journal of Clinical Psychiatry, 49 (Suppl 8), 12-17.
24. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ and Eigen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side-effects in neuroleptic treated patients. Acta Psychiatrica Scandinavica, 76 (Suppl 334).
25. Montgomery SA (1988) 5HT uptake inhibitors in the treatment of depression. In: Citalopram. The New Antidepressant from Lundbeck Research (Ed SA Montgomery) XXII Nordisk Psykiater-Kongres, Reykjavik, 10-13 August 1988.
26. Montgomery SA (1989) New antidepressants and 5HT inhibitors. Acta Psychiatrica Scandinavica 1989, 80 (Suppl 350), 107-116.
27. Montgomery SA and Rasmussen JGC (1992) Citalopram 20 mg, Citalopram 40 mg and placebo in the prevention of relapse of major depression. International Clinical Psychopharmacology, (Suppl 5), 2, 71-73.
28. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M et al. (1992) A controlled multicentre clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatrica Scandinavica, 86, 138-145.
29. Scott J, Eccleston D and Boys R (1992) Can we predict the persistence of depression? British Journal of Psychiatry, 161, 633-637.
30. Silverstone T (1992) New aspects in the treatment of depression. International Clinical Psychopharmacology, (Suppl 5), 3, 41-44.
31. Timmerman L, de Beurs P, Tan BK, Leynse-Ybema H, Sanchez C, Høpfner Petersen HE et al. (1987) A double-blind comparative trial of citalopram vs maprotiline in hospitalized depressed patients. International Clinical Psychopharmacology, 2, 239-253.
32. Zitman FG, Griez EJL and Hooijer (1989) Standaardisering depressievragenlijsten. Tijdschrift voor Psychiatrie, 31, 114-135.
33. Zung WWK (1965) A self rating depression scale. Archives of General Psychiatry, 12, 63-70.